Regulatory translation demands more than language expertise — it requires complete familiarity with global compliance frameworks and submission standards. LingArch’s professional pharmaceutical regulatory translation services support every stage of your product lifecycle, ensuring your documents are regulator-ready across multiple markets.
- Clinical Trial Applications (CTAs)
- Common Technical Documents (CTD)
- Product Information Leaflets (PILs)
- Summary of Product Characteristics (SmPCs)
- Regulatory submissions for MHRA, EMA, and FDA
- Documents aligned with ICH E3, E6, and M4 requirements
- eCTD-ready formatting support
Using advanced translation memory tools and terminology management systems, we maintain consistency, precision, and version accuracy across all documents — even in the most complex regulatory environments.
Types of Pharmaceutical Documents We Translate
Our expert team translates a wide range of technical, scientific, and regulatory documentation, including:
- Clinical research reports and drug trial protocols
- Investigator brochures and pharmacovigilance reports
- Informed consent forms and patient information leaflets
- Labelling, packaging inserts, and product monographs
- Manufacturing SOPs and quality control documentation
- Medical device manuals and compliance certificates
- Adverse event reports and safety summaries
We support pharmaceutical companies, contract research organisations, biotech firms, hospitals, and research institutions worldwide — providing compliant documentation in 120+ languages.
For legal and intellectual property needs, LingArch also supports patent translation for pharmaceutical and biotechnology submissions.